PIRSA:14050059

Validation of predicted mRNA splicing mutations using high-throughput transcriptome data

Viner, C. (2014). Validation of predicted mRNA splicing mutations using high-throughput transcriptome data. Perimeter Institute. https://pirsa.org/14050059

Viner, Coby. Validation of predicted mRNA splicing mutations using high-throughput transcriptome data. Perimeter Institute, May. 07, 2014, https://pirsa.org/14050059 

          @misc{ pirsa_PIRSA:14050059,
            doi = {10.48660/14050059},
            url = {https://pirsa.org/14050059},
            author = {Viner, Coby},
            keywords = {},
            language = {en},
            title = {Validation of predicted mRNA splicing mutations using high-throughput transcriptome data},
            publisher = {Perimeter Institute},
            year = {2014},
            month = {may},
            note = {PIRSA:14050059 see, \url{https://pirsa.org}}
          }

Coby Viner

DOI 10.48660/14050059
Collection
Talk Type Conference

Abstract

This work has been published:Viner C Dorman SN Shirley BC and Rogan PK (2014)Validation of predicted mRNA splicing mutations using high-throughput transcriptome data [v1; ref status: indexedhttp://f1000r.es/2no]F1000Research20143:8 (doi:10.12688/f1000research.3-8.v1)Additionally this work has been accepted for a highlights presentation at the upcoming Great Lakes Bioinformatics Conference (GLBIO) in Cincinnati Ohio and it was recently presented as a poster at London Health Research Day (LHRD).Abstract:Interpretation of variants present in complete genomes or exomes reveals numerous sequence changes only a fraction of which are likely to be pathogenic. Variants predicted to alter mRNA splicing in particular can be validated by manual inspection of transcriptome sequencing data however this approach is intractable for large datasets. We show that abnormal mRNA splicing patterns are characterized by reads demonstrating either exon skipping cryptic splice site use and high levels of intron inclusion or combinations of these properties. This paper presents Veridical an in silico method for the automatic validation of DNA sequencing variants that alter mRNA splicing. Veridical leverages large numbers of control samples (that lack a putative mutation) applying z-tests to Yeo-Johnson transformed data to normalize read counts of abnormal RNA species in mutant versus non-mutant tissues. With the transformed data the null hypothesis based mainly on either counts of intronic or junctional reads can be rejected for true splicing mutations using conventional parametric statistical methods.